Broncus Technologies, Inc.

Company Summary

Broncus Technologies develops and sells innovative solutions for diagnosing and treating lung diseases. The Company’s LungPoint® system allows physicians to plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its FleXNeedle™ catheter is used to obtain biopsy samples and access to hard-to-reach targets.

Transaction Overview

On 22, October, 2012, LifeTech Scientific Corporation, DiNova Venture Partners, and

Themes Investment Partners, and Broncus Technologies, announced a global strategic

partnership through the formation of Broncus Medical.

Significance of the Transaction

Following a recent strategic partnership with Medtronic, the acquisition will allow LifeTech Scientific to increase revenue generation from a novel technology as well as launch into a large and growing market (China). Today, LifeTech Scientific is worth over ‘6x’ its value from the time of the transaction.

Healthios Role

Healthios (Third500) served as exclusive adviser to Broncus Technologies.

This transaction highlights Healthios (Third500) commitment to creative deal

structure capitalizing on company milestones and market opportunity while

considering shareholder interest.

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mergers & Acquisitions
Broncus Technologies, Inc.
Has been aquired by
The undersigned acted as exclusive financial advisor to Broncus
Read More